Englewood Lab IPO Preview (Part 2) - Valuation Analysis
Our comparable companies valuation analysis suggests a 61% upside for Englewood Lab shares over a one-year period. We used five leading...
476 Views
Englewood Lab IPO Preview (Part 1) - CEO Presentation to Investors
Englewood Lab (950140 KS) held an IR presentation to investors on September 23rd in Seoul. The Founder& CEO Mr. David Chung was the key...
686 Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.5k Views